Cancer Vaccine
Here's an encouraging development:
Washington, DC — More than twenty years of collaborative research in the Georgetown lab of Dr. Richard Schlegel has resulted in a major medical breakthrough — the world’s first cancer vaccine.
The vaccine's technology was generated by a team of Georgetown University researchers in the early 1990s and licensed for commercial development. On June 8, the Food and Drug Administration approved the vaccine, which scientists say could eliminate most new cases of cervical cancer worldwide. Called Gardasil, the vaccine blocks four strains of HPV, including two that give rise to nearly 75 percent of cervical cancer cases and two other strains that cause about 50 percent of genital warts.
“It’s a researcher’s dream … to see something that started as a very cerebral idea in the laboratory to advance through animal and clinical trials, gain FDA approval and ultimately have a major global impact,” Schlegel said. “It’s highly unlikely but extremely gratifying to see it through so far.”
So that's one down, many to go. A good start!
Hat-tip: Boulder Future Salon